ESPN, Inc., widely recognized as The Worldwide Leader in Sports, has announced a substantial funding round totaling $2 billion, a testament to its position at the forefront of sports entertainment. This funding will significantly bolster ESPN鈥檚 ability to expand its extensive portfolio, which includes over 50 multifaceted multimedia sports assets such as domestic cable networks like ESPN, ESPN2, and ESPN Deportes, as well as its growing digital platforms like ESPN.com and ESPN360.com. As the sports landscape rapidly evolves with an increasing demand for high-quality content across both traditional and digital mediums, this capital injection will be strategically allocated to enhance ESPN鈥檚 technological capabilities and further develop cutting-edge broadcast solutions. Plans are underway to invest in innovative programming and partnerships that will amplify the viewing experience and continue to engage millions of sports fans worldwide. Additionally, the funding will support ESPN's international endeavors, ensuring that their premier sports content reaches an even broader audience across the globe. With a firm foundation built on strong ownership by ABC, Inc. (an indirect subsidiary of The Walt Disney Company) and substantial equity from The Hearst Corporation, ESPN is poised to leverage this investment to solidify its competitive edge in the ever-changing sports media landscape. As the company marches towards its goal of delivering unparalleled sports entertainment, fans can anticipate exciting new developments that will enhance their viewing experience across various platforms.
ESPN Lands $2 Billion in Funding for Multimedia Sports Expansion
Recently funded 路 $2.0BSports
Get the full ESPN company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Epitome Therapeutics
Epitome Therapeutics is a biotechnology company advancing precision epigenome editing for programmable gene expression. Founded in 2025 as a spin-off from EMBL, Epitome is developing CADENCE, a next-generation platform designed to enable the precise and durable calibration of gene dosage without altering the underlying DNA sequence. The company aims to establish new therapeutic approaches for diseases driven by dysregulated gene activity, including rare and metabolic disorders.
$2.3M Pre-seed
today
Xentra
From cyber security, through to safeguarding and compliance, we provide digital security solutions perfectly designed to suit any requirement. Our team of experts will help you assess, select and implement the right solutions for your organisation; setting you up for success and helping you deliver against key objectives. We pride ourselves on understanding the digital security landscape, thoroughly evaluating available technologies and building long-term partnerships with our customers. We don鈥檛 believe in quick fixes. Whether you require a point solution to tackle a single requirement, or would benefit from a complete managed service, our solutions are built to stand the test of time. Since 2020, we鈥檝e been helping organisations such as Leeds United Football Club, Thomas鈥檚 London Day Schools, Setfords, JT Atkinson and Northern Estate Agencies Group, manage and optimise their overall digital security. Along the way, we have set the standard for what a customer-first approach to digital security looks like, and how to measure success.
